These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5029206)

  • 1. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 2. [New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].
    Garassini G; Sarnari V
    Minerva Gastroenterol; 1974; 20(1):19-26. PubMed ID: 4827982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary clinico-geriatric trials of S-adenosylmethionine (coenzyme of biologic transmethylation)].
    Cavalieri U; Leonelli G
    Minerva Med; 1972 May; 63(37):2120-5. PubMed ID: 5031032
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
    Cantoni L; Maggi G; Mononi G; Preti G
    Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study].
    Ideo G
    Minerva Med; 1975 May; 66(33):1571-80. PubMed ID: 1095962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes induced by S-adenosylmethionine (SAM) in the cholesterol and triglyceride plasma levels and in the beta-alpha lipoprotein ratio in cases of hyperlipemia. (Preliminary note)].
    Menci S; Orsucci PL
    G Gerontol; 1972 Jun; 20(6):523-33. PubMed ID: 5046892
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the histochemical properties and origin of lipofuscin in certain pathological conditions of the liver].
    Zolotarevskiĭ VB
    Arkh Patol; 1968; 30(1):21-4. PubMed ID: 4297042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 14. S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet.
    Esfandiari F; You M; Villanueva JA; Wong DH; French SW; Halsted CH
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1231-9. PubMed ID: 17577393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical importance of diets enriched with lipotropic factors in chronic hepatic lesions].
    Beiul EA; Iatsyshina TA; Volgarev MN; Korobkina GS; Odintsova IL; Kalinina NN; Trofimova OM
    Vopr Pitan; 1967; 26(4):40-5. PubMed ID: 4180800
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clevage of exogenous lipids in patients with chronic hepatic disease].
    Shaternikov VA; Loranskaia TI; Beiul EA; Savchuk LA
    Vopr Pitan; 1969; 28(2):11-6. PubMed ID: 5367242
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 18. What is SAMe? S-Adenosylmethionine.
    Cowley G; Underwood A
    Newsweek; 1999 Jul; 134(1):46-50. PubMed ID: 10538206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism pathways and use of heptral in chronic liver diseases].
    Il'chenko LIu; Vinnitskaia EV
    Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment.
    Varela-Moreiras G; Alonso-Aperte E; Rubio M; Gassó M; Deulofeu R; Alvarez L; Caballería J; Rodés J; Mato JM
    Hepatology; 1995 Oct; 22(4 Pt 1):1310-5. PubMed ID: 7557886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.